Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2008

01-02-2008

Establishing an inpatient anticoagulation service: a step by step review

Authors: John Viercinski, Lynda Thomson, Joseph Wilson, Geno J. Merli

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2008

Login to get access

Abstract

Inpatient anticoagulation services can reduce medication errors, reduce hospital costs, and improve patient care. However, before a hospital establishes an inpatient anticoagulation service, it is important to conduct a thoughtful, systematic review of the institution. Two factors that can determine the need for an inpatient anticoagulation service are the number of adverse drug events and the extent of medical-legal liability at the institution. Establishing an inpatient service that reduces these problems can justify the cost of the program. In addition to these factors, the institution’s infrastructure and the scope of services to be provided should be evaluated, and parameters should be created to measure the clinical and financial impact of the inpatient anticoagulation service. Numerous publications in the literature have supported the need and positive impact of inpatient anticoagulation services on hospital costs and patient care. The size and scope of the service should be based upon the needs, experiences and resources of a specific institution.
Literature
1.
go back to reference Leape LL, Bates DW, Cullen DJ et al (1995) Systems analysis of adverse drug events. JAMA 274:35–43PubMedCrossRef Leape LL, Bates DW, Cullen DJ et al (1995) Systems analysis of adverse drug events. JAMA 274:35–43PubMedCrossRef
2.
go back to reference Bates DW, Cullen DJ, Laird N et al (1995) Incidence of adverse drug events and potential adverse drug events. JAMA 274:29–34PubMedCrossRef Bates DW, Cullen DJ, Laird N et al (1995) Incidence of adverse drug events and potential adverse drug events. JAMA 274:29–34PubMedCrossRef
3.
go back to reference Fanikos J, Stapinski C, Koo S et al (2004) Medication errors associated with anticoagulant therapy in the hospital. Am J Cardiol 94:532–535PubMedCrossRef Fanikos J, Stapinski C, Koo S et al (2004) Medication errors associated with anticoagulant therapy in the hospital. Am J Cardiol 94:532–535PubMedCrossRef
4.
go back to reference Rothschild JM, Federico FA, Gandhi TK et al (2002) Analysis of medication related malpractice claims: causes, preventability, and costs. Arch Intern Med 162:2414–2420PubMedCrossRef Rothschild JM, Federico FA, Gandhi TK et al (2002) Analysis of medication related malpractice claims: causes, preventability, and costs. Arch Intern Med 162:2414–2420PubMedCrossRef
5.
go back to reference Hylek EM, Regan S, Henault LE et al (2003) Challenges to the effective use of unfractioned heparin in the hospitalized management of acute thrombosis. Arch Intern Med 163:621–627PubMedCrossRef Hylek EM, Regan S, Henault LE et al (2003) Challenges to the effective use of unfractioned heparin in the hospitalized management of acute thrombosis. Arch Intern Med 163:621–627PubMedCrossRef
6.
go back to reference Pawloski SJ, Kersh PL (1992) Therapeutic heparin monitoring service in a small community hospital. Hosp Pharm 27:703–706PubMed Pawloski SJ, Kersh PL (1992) Therapeutic heparin monitoring service in a small community hospital. Hosp Pharm 27:703–706PubMed
7.
go back to reference Fanikos J, Fiumara K, Baroletti S et al (2007) Impact of smart infusion technology on administration of anticoagulants (unfractionated heparin, argatroban, lepirudin, and bivalirudin). Am J Cardiol 99:1002–1005PubMedCrossRef Fanikos J, Fiumara K, Baroletti S et al (2007) Impact of smart infusion technology on administration of anticoagulants (unfractionated heparin, argatroban, lepirudin, and bivalirudin). Am J Cardiol 99:1002–1005PubMedCrossRef
8.
go back to reference Dager WE, Branch JM, King JH et al (2000) Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother 34:567–572PubMedCrossRef Dager WE, Branch JM, King JH et al (2000) Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother 34:567–572PubMedCrossRef
Metadata
Title
Establishing an inpatient anticoagulation service: a step by step review
Authors
John Viercinski
Lynda Thomson
Joseph Wilson
Geno J. Merli
Publication date
01-02-2008
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2008
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-007-0111-z

Other articles of this Issue 1/2008

Journal of Thrombosis and Thrombolysis 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.